A randomized double-blind trial of comparative efficacy and safety of Avonex and CinnoVex for treatment of relapsing-remitting multiple sclerosis
ConclusionAvonex and CinnoVex showed similar efficacy and safety outcome in patients with RRMS.
Source: Neurological Sciences - Category: Neurology Source Type: research
More News: Avonex | Brain | Depression | Disability | Headache | Iran Health | Middle East Health | Migraine | Multiple Sclerosis | Neurology | Pain | Rebif | Statistics | Study